FDA grants Jacobus Pharma approval for rare disease drug
Jacobus Pharmaceutical Co Inc on Monday won U.S. approval for the first drug to treat children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Autoimmune Disease | Children | Grants | Health | Myasthenia Gravis | Pharmaceuticals | Rare Diseases